Navigation Links
Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
Date:3/31/2008

ly dementia and ADHD. The Company's lead molecular imaging product candidate is ALTROPANE(R) which is in Phase III clinical trials for the diagnosis of Parkinsonian Syndromes including Parkinson's Disease. The Company has research collaborations with Harvard Medical School and Children's Hospital Boston.

Forward-Looking Statements

The foregoing release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements include statements regarding Alseres' future expectations, beliefs, intentions, goals, strategies, plans or prospects regarding the future, including the development and commercialization of ALTROPANE and CETHRIN, the prospects of the Company's CNS and regenerative therapeutics programs, the Company's strategies to develop and commercialize axon regeneration technologies and the breadth of the Company's technologies and intellectual property portfolio. Forward-looking statements can be identified by terminology such as "anticipate," "believe," "could," "could increase the likelihood," "estimate," "expect," "intend," "is planned," "may," "should," "will," "will enable," "would be expected," "look forward," "may provide," "would" or similar terms, variations of such terms or the negative of those terms. Such forward-looking statements involve known and unknown risks, uncertainties and other factors including those risks, uncertainties and factors referred to in the Company's Annual Report on Form 10-K for the year ended December 31, 2007 filed with the Securities and Exchange Commission under the section "Risk Factors," as well as other documents that may be filed by Alseres from time to time with the Securities and Exchange Commission. As a result of such risks, uncertainties and factors, the Company's actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained he
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Raises $5 Million
2. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
3. Barr Pharmaceuticals, Inc. Executive Bios
4. Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
5. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
6. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
7. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
8. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
9. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
10. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
11. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... the human eye, the brain of a rat and ... technology, says a QUT leading robotics researcher. , ... says the new study uses new computer algorithms to ... or tunnels. , "This is a very Frankenstein type ... halves of a thing together because we,re taking the ...
(Date:10/1/2014)... Patients with increased inflammation, including those receiving cytokines ... of depression. For example, a 6-month treatment course ... infection causes depression in approximately 30% of patients. ... as fish oil, have a long list of ... disease and reducing triglyceride levels. These nutritional compounds ...
(Date:10/1/2014)... New research suggests the adage that encourages people to ... target when it comes to exercise. When walking, staying ... distance to it appear shorter and help people walk ... compares this technique to walking while looking around the ... quality of exercise. , "People are less interested in ...
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog ... couples. , Senior citizens can purchase a joint ... loved ones. A joint policy is cheaper, but will ... , Life insurance can be used to cover ... be purchased online, as the application process is simple ...
(Date:10/1/2014)... 2014 Bedros Keuilian is not only ... fitness boot camps, he’s also considered the leading expert ... sold out business summits, a line of high-demand fitness ... a recent Spike TV reality show to his name. ... the time for personal trainers and fitness business owners ...
Breaking Medicine News(10 mins):Health News:Robot researcher combines nature to nurture 'superhuman' navigation 2Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3
... trips to their GP under a new scheme that has ... The electronic transfer of repeat prescriptions between general practices and ... a bid to streamline the system and make it faster ... down on prescription errors. , And now the scheme is ...
... be much tougher than is typically done, study finds , ... small (1 centimeter or less), certain kinds of breast cancer ... researchers say. , A team at the Mayo Clinic in ... (HER2+) and triple negative (HER2- and ER/PR-) tumors that have ...
... (Oakland, Calif.) The Agency for Healthcare Research and ... Health Research for a study that uses electronic medical ... 175,000 adults to find ways to improve the quality ... which will begin to yield findings next summer, will ...
... Dec. 17 Incisionless surgery is the,most significant ... being,rapidly adopted by a wide variety of academic ... StomaphyX(TM) and EsophyX(TM) procedures already,performed globally. Despite the ... clearance this year, over 50 U.S. centers,have already ...
... babies are born with severe heart defects that must be operated ... odds for these infants are much better now than they were ... be a way to give them an even better chance at ... at handling such cases. , In the first national study of ...
... Find items or activities that stretch youngsters, creativity and ... 16 (HealthDay News) -- When you,re Christmas shopping for ... toys that promote healthy childhood development and reinforce personal ... allow for creativity, imagination, manipulation, and change. If a ...
Cached Medicine News:Health News:Prescription for an electronic revolution? 2Health News:Prescription for an electronic revolution? 3Health News:Even Tiny Breast Tumors May Need Aggressive Treatment 2Health News:Agency for Healthcare Research and Quality funds KP study of electronic records for heart disease 2Health News:EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures 2Health News:EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures 3Health News:EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures 4Health News:For babies with heart defects, death risk is far lower at most experienced hospitals 2Health News:For babies with heart defects, death risk is far lower at most experienced hospitals 3Health News:For babies with heart defects, death risk is far lower at most experienced hospitals 4Health News:Picking the Right Toys Isn't Child's Play 2
(Date:10/1/2014)... , Suisse, October 1, 2014 ... et dans le domaine de l,analyse des données ... aujourd,hui une solution de diagnostic in vitro (IVD) ... analyse complète de la mucoviscidose dans un seul ... de caractériser tous les types de variantes par ...
(Date:9/30/2014)... report analyzes the worldwide markets for Enteral Feeding Devices in ... Nasogastric Tubes, and Others. The report provides separate ... , Europe , Asia-Pacific ... World. Annual estimates and forecasts are provided for the period ... for these markets. The report profiles 38 companies ...
(Date:9/30/2014)... Sept. 30, 2014 MiMedx Group, Inc. (NASDAQ: ... utilizing human amniotic tissue and patent-protected processes to develop ... Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental ... , Ph.D., Chief Scientific Officer, will present at the ... present on Tuesday, October 7, 2014, at 5:00PM Pacific ...
Breaking Medicine Technology:Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Global Enteral Feeding Devices Industry 2Global Enteral Feeding Devices Industry 3Global Enteral Feeding Devices Industry 4Global Enteral Feeding Devices Industry 5Global Enteral Feeding Devices Industry 6Global Enteral Feeding Devices Industry 7Global Enteral Feeding Devices Industry 8Global Enteral Feeding Devices Industry 9Global Enteral Feeding Devices Industry 10Global Enteral Feeding Devices Industry 11Global Enteral Feeding Devices Industry 12Global Enteral Feeding Devices Industry 13Global Enteral Feeding Devices Industry 14Global Enteral Feeding Devices Industry 15Global Enteral Feeding Devices Industry 16Global Enteral Feeding Devices Industry 17Global Enteral Feeding Devices Industry 18Global Enteral Feeding Devices Industry 19MiMedx to Present at the Stem Cell Meeting on the Mesa 2
... Feb. 14, 2011 Thoratec Corporation (Nasdaq: THOR ... to save, support and restore failing hearts, announced today that ... to $100 million of the company,s shares of common stock ... confidence in the long-term strength of the company, as well ...
... 14, 2011 Mesa Laboratories, Inc. (Nasdaq: ... has declared a regular quarterly cash dividend of 12 ... 15, 2011 to shareholders of record at the close ... Laboratories develops, acquires, manufactures and markets electronic instruments and ...
Cached Medicine Technology:Thoratec Corporation Authorizes $100 Million Share Repurchase Program 2Thoratec Corporation Authorizes $100 Million Share Repurchase Program 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Medicine Products: